Health: soon a vaccine to protect babies from bronchiolitis? -RTL

The imminent return of winter raises fears of many new cases of bronchiolitis. This disease, which mainly affects newborns but also the elderly, is an acute respiratory viral infection affecting the bronchioles. This particularly dangerous winter virus causes inflammation that leads to respiratory discomfort. Signs of this disease include a strong cough and wheezing and rapid breathing. But the Sanofi laboratory may hold the keys to a vaccine aimed at combating this virus. Developed in collaboration with AstraZeneca, this vaccine is an antibody injection intended for infants in their first year. Tests carried out on nearly 2,300 children have ensured that it was well tolerated and can protect babies for the whole winter with a single injection. The laboratory ensures an effectiveness of nearly 80% against serious forms of bronchiolitis, which makes it the most advanced vaccine on the subject. The results have already been sent to the European Medicines Agency (EMA), which should issue a marketing authorization by November. Not before winter 2023 However, this vaccine will not be available this winter. After the green light from the EMA, it is the French authorities who will have to study the clinical data and decide. This process generally lasts nearly a year, especially since the price of the vaccine will then have to be negotiated. The French laboratory therefore hopes that the first injections will be delivered for the winter of 2023. The editorial staff recommends L’actualité by RTL editorial staff to your mailbox. Thanks to your RTL account, subscribe to the RTL info newsletter to follow all the news on a daily basis Read more